Left behind: should minimal residual disease be treated in hairy cell leukemia?

Leuk Lymphoma. 2014 May;55(5):971-2. doi: 10.3109/10428194.2013.866667. Epub 2014 Mar 7.

Authors

Jae H Park¹, Martin S Tallman

Affiliation

¹ Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College , New York, NY , USA.

PMID: 24512318
DOI: 10.3109/10428194.2013.866667

No abstract available

Publication types

Comment

MeSH terms

Cladribine / therapeutic use*
Female
Humans
Leukemia, Hairy Cell / drug therapy*
Male
Pentostatin / therapeutic use*

Substances

Pentostatin
Cladribine